Genprex Inc is a clinical stage gene therapy company. It is engaged in developing a new approach to treating cancer based on its novel proprietary technology platform, including initial product candidate, Oncoprex immunogene therapy. Oncoprex, which has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis in cancer cells and modulates the immune response against cancer cells.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-28 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.140 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| GNPX | Genprex | -5.16% | 183.1M |
Genprex Company Questions & Answers
Q
How do I buy Genprex (GNPX) stock?
A
You can purchase shares of Genprex (NASDAQ: GNPX) through any online brokerage.
Q
Who are Genprex's (GNPX) main competitors?
A
There are no as such competitors for Genprex.
Q
What is the target price for Genprex?
A
The latest price target for Genprex (NASDAQ: GNPX) was reported by Maxim Group on 2018-09-14. The analyst firm set a price target for 5.00 expecting GNPX to rise to within 12 months (a possible 18.20% upside). 0 analyst firms have reported ratings in the last year.
Q
How much is Genprex (GNPX) stock ?
A
The stock price for Genprex (NASDAQ: GNPX) is $4.23 last updated Mon Apr 12 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
Q
When is the next Genprex (GNPX) dividend?
A
There are no upcoming dividends for Genprex.
Q
When is Genprex (NASDAQ:GNPX) reporting earnings?
A
Genprex’s Q1 earnings are confirmed after-market from now on May 28, 2021.
Q
When is the upcoming split for GNPX?
A
There is no upcoming split for Genprex.